The definitive merger agreement stipulates that GHO and Ampersand will purchase all outstanding shares of Avid.

Integrating technology and sustainability is essential for optimising workplace efficiency and enhancing client experiences ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...

The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

NEW YORK CITY, NY / ACCESSWIRE / November 13, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...

Avid Bioservices (NASDAQ:CDMO) has agreed to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at around $1.1B.

Avid Bioservices (CDMO) has agreed to be acquired by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at $1.1B. Read more here.

Under the terms of the merger agreement, GHO and Ampersand would acquire all the outstanding shares held by Avid’s stockholders for $12.50 per share in cash. The per share purchase price represents a ...

BOSTON, Oct. 31, 2024 /PRNewswire/ -- For the third consecutive year, Ampersand Capital Partners has been named to Inc.'s 2024 Founder-Friendly Investors list, which honors the private equity and ...

Ampersand reaches 1150 bikes on the roads of Nairobi Expansion underscores company's commitment to cutting carbon emissions and driving clean economic prosperity across Africa Nairobi – Ampersand, ...